+578.2%
CDNS vs MRNA
+554.4%
+23.7%
-32.1%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 10y.
| Period | Portfolio | MRNA | Excess | Alpha |
|---|---|---|---|---|
| 1D | +1.6% | +5.4% | -3.8% | +1.3% |
| 7D | -1.1% | -1.1% | -0.1% | -1.1% |
| 30D | -10.4% | +126.1% | -136.6% | -17.9% |
| 3M | -24.6% | +190.0% | -214.6% | -32.8% |
| 6M | -1.6% | +157.2% | -158.9% | -11.6% |
| YTD | -7.4% | +388.2% | -395.6% | -22.0% |
| 1Y | -18.4% | +467.0% | -485.5% | -32.5% |
| 3Y | +19.0% | +36.1% | -17.1% | +7.6% |
| 5Y | +73.4% | -68.0% | +141.4% | +64.7% |
| All | +578.2% | +554.4% | +23.7% | +489.4% |
Cumulative growth
Daily Returns
Daily percentage return beside MRNA.
Daily Out/Under-Performance
Portfolio return minus MRNA return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × MRNA return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 10y: compounded portfolio wealth divided by compounded MRNA wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
10y analysis · Full analysis span regression · 6 months rolling